Finance

Lists
000950:SHE
C.Q. Pharmaceutical Holding Co Ltd
CN¥5.03
+0.60%
(+0.030) 1D
Oct 30, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000950...
Open
CN¥4.98
High
CN¥5.11
Low
CN¥4.94
Mkt. cap
8.62B
Avg. vol.
14.87M
Volume
18.90M
Dividend
1.19%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 18, 2026
P/E ratio
26.81
52-wk high
CN¥7.41
52-wk low
CN¥4.79
EPS
CN¥0.19
Shares outstanding
1.71B
No. of employees
12K
Open
CN¥4.98
High
CN¥5.11
Low
CN¥4.94
Mkt. cap
8.62B
Avg. vol.
14.87M
Volume
18.90M
Dividend
1.19%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 18, 2026
P/E ratio
26.81
52-wk high
CN¥7.41
52-wk low
CN¥4.79
EPS
CN¥0.19
Shares outstanding
1.71B
No. of employees
12K
News stories
From web sources and news partners
About C.Q. Pharmaceutical Holding Co Ltd
CEO-
Employees12.2K
FoundedMay 28, 1999
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
20.24B
20.43B
19.70B
20.14B
Cost of goods sold
18.89B
19.03B
18.39B
18.74B
Cost of revenue
18.89B
19.03B
18.39B
18.74B
Research and development expenses
354.97K
395.95K
-35.18K
116.04K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15B
812.02M
863.01M
924.33M
Operating expense
1.29B
1.11B
1.04B
1.15B
Total operating expenses
20.18B
20.14B
19.43B
19.89B
Operating income
51.72M
292.09M
272.36M
256.59M
Other non operating income
-136.86M
-5.51M
1.79M
-18.02M
EBT including unusual items
14.42M
245.28M
172.85M
139.09M
EBT excluding unusual items
28.89M
230.14M
159.56M
197.60M
Income tax expense
25.47M
46.91M
58.69M
46.43M
Effective tax rate
176.61%
19.13%
33.95%
33.38%
Other operating expenses
50.20M
48.35M
46.68M
26.27M
Net income
2.70M
170.73M
83.72M
66.08M
Net profit margin
0.01%
0.84%
0.42%
0.33%
Earnings per share
-
-
-
-
Interest and investment income
285.43M
106.06M
47.93M
126.94M
Interest expense
-171.42M
-162.50M
-162.56M
-167.86M
Net interest expenses
114.02M
-56.44M
-114.64M
-40.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
116.81M
357.19M
332.76M
321.69M
Gain or loss from assets sale
-4.63M
-
-3.88M
3.88M
Upcoming events
AI content may include mistakes. Learn more
Google apps